查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
家庭化疗服务市场，按产品类型、癌症类型、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1419023

家庭化疗服务市场，按产品类型、癌症类型、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Chemotherapy At Home Services Market, By Product Type, By Cancer Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 285 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年家庭化疗服务市场规模为 15.08 亿美元，2023 年至 2030 年复合CAGR为 8.5%。

家庭化疗服务市场-市场动态

家庭化疗服务市场的成长预计将受到不同类型癌症发生率的增加以及患者从医院转向家庭护理环境的成长趋势的推动。

许多人表示愿意尽可能在自己舒适的家中接受医疗照护。透过在家庭环境中提供医疗保健服务，可以提高患者的便利性并减轻频繁去医院就诊的负担。随着癌症病例数量持续增加，医疗机构可能面临越来越大的压力和对其服务的需求。居家化疗服务允许患者在非医院环境中接受治疗，有助于缓解部分压力。根据美国国家卫生统计中心预测，2023年，美国将新增癌症病例1,958,310例，癌症相关死亡人数将达609,820例。便携式输液帮浦和远端监控设备等医疗技术的进步为家庭化疗服务市场提供了成长机会。然而，重要的是要解决安全问题并考虑这些服务的有限适用性，因为它们可能会阻碍市场的成长。

居家化疗服务市场 - 主要见解

  • 根据我们的研究分析师分享的分析，预计全球家庭化疗服务市场在预测期内（2023-2030 年）每年将以 8.5% 左右的CAGR成长
  • 根据产品类型细分，预计 Oral 将在 2022 年显示最大的市场份额
  • 根据癌症类型细分，白血病是 2022 年的主要类型
  • 按地区划分，北美是 2022 年的主要收入来源

家庭化疗服务市场-細項分析：

全球家庭化疗服务市场根据产品类型、癌症类型和地区进行细分。

根据产品类型，市场分为三类：口服和输液。该市场主要由口腔领域主导。口服化疗药物有药丸或胶囊的形式，方便患者在家服用。这为他们提供了更大的灵活性和自我管理的选择。肿瘤科医师通常会开立口服化疗药物，患者可以方便地从药局取得药物。某些药局甚至提供口服化疗药物的专门服务。

根据癌症类型，市场分为两类：乳癌、结肠癌、直肠癌、子宫颈癌、肺癌、摄护腺癌、卵巢癌和白血病。白血病细分市场占据主导地位。该市场主要由白血病细分市场控制。白血病分为两种主要形式，即急性和慢性，并进一步分为骨髓型和淋巴型。所采用的治疗方法取决于白血病的确切类型和亚型。化疗是白血病的常见治疗方式，尤其是急性白血病。它涉及使用药物杀死或控制白血病细胞的生长。

家庭化疗服务市场 - 地理洞察

从地理来看，该市场遍布北美、拉丁美洲、欧洲、亚太、中东和非洲等多个地区。这些区域根据参与商业活动的国家进一步划分。北美市场预计将主导成长，这主要是由于癌症治疗的家庭输液服务需求不断增长所推动的。如果北美癌症发生率上升，对化疗等癌症治疗服务的需求可能会激增。这种不断增长的需求可能会导致需要更方便、更方便患者的选择，例如家庭服务。据估计，每年约有 170 万美国人被诊断出罹患癌症。在诊断后一年内，四分之三的晚期癌症患者最终住院，其中六分之一的人住院三次或以上。此外，根据健康和医学前沿报道，几乎每个需要化疗的人每天都会在医生办公室或门诊诊所度过几个小时。由于家庭化疗服务的需求不断增加，欧洲是预测期内市场成长的第二大地区。

居家化疗服务市场-竞争格局：

虽然医院仍然是儿科癌症护理的主要地点，但在家庭环境中提供护理的趋势日益增长。为了确保在家中为儿童提供全面和适当的护理，考虑关键知情人的观点至关重要。加拿大、美国、澳洲和欧洲等国家正在扩大儿童的居家照护服务和治疗，包括静脉化疗、化疗后补水、低风险发烧性嗜中性白血球减少症监测和药物输注。製造商正在积极寻求儿童、家庭照顾者和临床医生的意见，以改善家庭癌症护理服务。这包括确定与在家中接受或提供护理相关的好处和挑战，以及进行必要的修改以提高计划的可接受性和感知有用性。製药公司正在与家庭医疗保健提供者合作，为在家接受化疗的患者提供支援服务和资源。这些合作旨在改善患者教育和遵守治疗计划。除了国家提供者之外，地方和区域家庭医疗保健机构也可以与肿瘤学家和医院合作提供家庭化疗服务，将癌症护理扩展到患者家中。

最近的发展：

2023 年 7 月，DispatchHealth 与 Reimagine Care 结成策略联盟，以促进家庭癌症治疗。此次合作减少了急诊室就诊次数和意外住院时间。

目录

第 1 章：家庭化疗服务市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的家庭化疗服务市场片段
    • 按癌症类型分類的家庭化疗服务市场片段
    • 家庭化疗服务市场片段（按国家/地区）
    • 按地区分類的家庭化疗服务市场片段
  • 竞争洞察

第 3 章：家庭化疗服务主要市场趋势

  • 居家化疗服务市场驱动因素
    • 市场驱动因素的影响分析
  • 居家化疗服务市场限制
    • 市场限制影响分析
  • 居家化疗服务市场机会
  • 居家化疗服务市场未来趋势

第 4 章：家庭化疗服务业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：居家化疗服务市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：居家化疗服务市场格局

  • 2022 年居家化疗服务市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：家庭化疗服务市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 口服
    • 点滴

第 8 章：居家化疗服务市场 - 按癌症类型

  • 概述
    • 按癌症类型分類的细分市场份额分析
    • 乳癌
    • 结肠癌
    • 直肠癌
    • 子宫颈癌
    • 肺癌
    • 摄护腺癌
    • 卵巢癌
    • 白血病

第 9 章：居家化疗服务市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 家庭化疗服务北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按癌症类型）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 家庭化疗服务欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按癌症类型）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 家庭化疗服务亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模和预测（按癌症类型）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 家庭化疗服务拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按癌症类型）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 家庭化疗服务中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按癌症类型）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 家庭化疗服务产业

  • 竞争仪表板
  • 公司简介
    • Sciensus Pharma Services Limited
    • Portea Medical
    • Ubiqare
    • Penn Medicine (The Trustees of the University of Pennsylvania)
    • Advocate Health Care
    • View Health Pty Ltd group (chemo@home Pty Ltd)
    • Vitalis Health and Home Care Pty Ltd
    • Medibank Private Limited
    • TCP Homecare
    • LloydsPharmacy Clinical Homecare

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2088

REPORT HIGHLIGHT

Chemotherapy At Home Services Market size was valued at USD 1,508 Million in 2022, expanding at a CAGR of 8.5% from 2023 to 2030.

Chemotherapy treatment at home offers several potential advantages. Firstly, it eliminates the need for frequent travel to hospital facilities, saving patients time and energy. Additionally, there is a reduced risk of acquiring infections that are commonly associated with hospitals. By receiving treatment in the comfort and security of their own homes, patients can experience a greater sense of ease and familiarity. This also minimizes disruptions to family life, allowing patients to maintain a sense of normalcy during their treatment. Moreover, receiving chemotherapy at home can provide patients with a heightened sense of control over their treatment and illness. To ensure accurate and up-to-date information on available services and any changes in the delivery of chemotherapy treatments, it is crucial to consult with healthcare providers or contact local healthcare authorities. While home healthcare services may be available for certain aspects of cancer care, such as home health nursing, supportive care, or palliative care, it is important to note that the administration of chemotherapy drugs may still require a controlled medical setting.

Chemotherapy At Home Services Market- Market Dynamics

The growth of the Chemotherapy At Home Services market is expected to be driven by the increasing incidence of different types of cancer and the growing trend of patients transitioning from hospital to home care settings.

Many individuals express a preference for receiving medical care in the comfort of their own homes whenever possible. By providing healthcare services in a home-based setting, it can enhance patient convenience and alleviate the burden of frequent hospital visits. As the number of cancer cases continues to rise, healthcare facilities may face increased pressure and demand for their services. Home-based chemotherapy services can help alleviate some of this pressure by allowing patients to receive treatment in a non-hospital environment. According to the National Center for Health Statistics, it is projected that in 2023, there will be 1,958,310 new cancer cases and 609,820 cancer-related deaths in the United States. The advancement of medical technology, such as portable infusion pumps and remote monitoring devices, presents a growth opportunity for the chemotherapy at home services market. However, it is important to address safety concerns and consider the limited applicability of these services, as they may hinder the market's growth.

Chemotherapy At Home Services Market- Key Insights

  • As per the analysis shared by our research analyst, the global Chemotherapy At Home Services market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2023-2030)
  • Based on product type segmentation, Oral was predicted to show maximum market share in the year 2022
  • Based on Cancer Type segmentation, Leukemia was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Chemotherapy At Home Services Market- Segmentation Analysis:

The Global Chemotherapy At Home Services Market is segmented on the basis of Product Type, Cancer Type and Region.

The market is divided into three categories based on product type: Oral and Infusion. The market is primarily dominated by the oral segment. Oral chemotherapy drugs are available in the form of pills or capsules, enabling patients to conveniently take them at home. This provides them with increased flexibility and the option of self-administration. Oncologists usually prescribe oral chemotherapy, and patients can conveniently obtain their medications from pharmacies. Certain pharmacies even provide specialized services for dispensing oral chemotherapy.

The market is divided into two categories based on Cancer Type: Breast Cancer, Colon Cancer, Rectum Cancer, Cervix Uteri Cancer, Lung Cancer, Prostate Cancer, Ovarian Cancer and Leukemia. Leukemia segment dominates the market. The market is predominantly controlled by the leukemia segment. Leukemia is classified into two main forms, namely acute and chronic, and further divided into myeloid and lymphoid types. The treatment methods employed depend on the precise type and subtype of leukemia. Chemotherapy is a common treatment modality for leukemia, particularly for acute forms. It involves the use of drugs to kill or control the growth of leukemia cells.

Chemotherapy At Home Services Market- Geographical Insights

Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The market in North America is expected to dominate the growth, primarily driven by the increasing demand for home infusion services for cancer treatment. In the event of a rise in cancer incidence in North America, there would likely be a surge in the demand for cancer treatment services, such as chemotherapy. This growing demand could lead to a need for more convenient and patient-friendly options like home-based services. It is estimated that approximately 1.7 million Americans are diagnosed with cancer each year. Within a year of diagnosis, three-quarters of those with advanced cancer end up being hospitalized, with 1 in 6 individuals being hospitalized three or more times. Additionally, almost everyone requiring chemotherapy spends several hours a day in physician offices or outpatient clinics, as reported by the frontiers of health and medicine. Europe holds the second-largest region for market growth during the forecast period, owing to the increasing demand for home-based chemotherapy services.

Chemotherapy At Home Services Market- Competitive Landscape:

While hospitals continue to be the primary location for pediatric cancer care, there is a growing trend towards providing care in the home setting. To ensure that comprehensive and appropriate care is delivered to children in their homes, it is crucial to consider the perspectives of key informants. Countries such as Canada, the United States, Australia, and Europe are expanding their home care services and treatments for children, including intravenous chemotherapy, post-chemotherapy hydration, monitoring of low-risk febrile neutropenia, and medication infusions. Manufacturers are actively seeking input from children, family caregivers, and clinicians to improve home-based cancer care services. This includes identifying the benefits and challenges associated with receiving or providing care at home, as well as making necessary modifications to enhance program acceptability and perceived usefulness. Pharmaceutical companies are collaborating with home healthcare providers to offer support services and resources for patients undergoing chemotherapy at home. These collaborations aim to improve patient education and adherence to treatment plans. In addition to national providers, local and regional home healthcare agencies may also offer at-home chemotherapy services in partnership with oncologists and hospitals, thereby extending cancer care to patients' homes.

Recent Developments:

In July 2023, a strategic alliance was formed between DispatchHealth and Reimagine Care to facilitate at-home cancer treatment. The collaboration lowers emergency room visits and unanticipated hospital stays.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET KEY PLAYERS

  • Portea Medical
  • Ubiqare
  • Penn Medicine (The Trustees of the University of Pennsylvania)
  • Advocate Health Care
  • View Health Pty Ltd group (chemo@home Pty Ltd)
  • Vitalis Health and Home Care Pty Ltd
  • Medibank Private Limited
  • TCP Homecare
  • LloydsPharmacy Clinical Homecare

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET, BY PRODUCT TYPE

  • Oral
  • Infusion

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET, BY CANCER TYPE

  • Breast Cancer
  • Colon Cancer
  • Rectum Cancer
  • Cervix Uteri Cancer
  • Lung Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Leukemia

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Chemotherapy At Home Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Chemotherapy At Home Services Market Snippet by Product Type
    • 2.1.2. Chemotherapy At Home Services Market Snippet by Cancer Type
    • 2.1.3. Chemotherapy At Home Services Market Snippet by Country
    • 2.1.4. Chemotherapy At Home Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Chemotherapy At Home Services Key Market Trends

  • 3.1. Chemotherapy At Home Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Chemotherapy At Home Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Chemotherapy At Home Services Market Opportunities
  • 3.4. Chemotherapy At Home Services Market Future Trends

4. Chemotherapy At Home Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Chemotherapy At Home Services Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Chemotherapy At Home Services Market Landscape

  • 6.1. Chemotherapy At Home Services Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Chemotherapy At Home Services Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Oral
    • 7.1.3. Infusion

8. Chemotherapy At Home Services Market - By Cancer Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Cancer Type, 2022 & 2030 (%)
    • 8.1.2. Breast Cancer
    • 8.1.3. Colon Cancer
    • 8.1.4. Rectum Cancer
    • 8.1.5. Cervix Uteri Cancer
    • 8.1.6. Lung Cancer
    • 8.1.7. Prostate Cancer
    • 8.1.8. Ovarian Cancer
    • 8.1.9. Leukemia

9. Chemotherapy At Home Services Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Chemotherapy At Home Services Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Chemotherapy At Home Services Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Chemotherapy At Home Services Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Chemotherapy At Home Services Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Chemotherapy At Home Services Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Chemotherapy At Home Services Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Sciensus Pharma Services Limited
    • 10.2.2. Portea Medical
    • 10.2.3. Ubiqare
    • 10.2.4. Penn Medicine (The Trustees of the University of Pennsylvania)
    • 10.2.5. Advocate Health Care
    • 10.2.6. View Health Pty Ltd group (chemo@home Pty Ltd)
    • 10.2.7. Vitalis Health and Home Care Pty Ltd
    • 10.2.8. Medibank Private Limited
    • 10.2.9. TCP Homecare
    • 10.2.10. LloydsPharmacy Clinical Homecare

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Chemotherapy At Home Services Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Chemotherapy At Home Services Market, by Product Type 2018-2030 (USD Million)
  • TABLE Chemotherapy At Home Services Market: Cancer Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Cancer Type
  • TABLE Global Chemotherapy At Home Services Market, by Cancer Type 2018-2030 (USD Million)
  • TABLE Chemotherapy At Home Services Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Chemotherapy At Home Services Market, by Region 2018-2030 (USD Million)
  • TABLE North America Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Europe Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Latin America Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)